Does ANASTROZOLE Cause Tumour marker increased? 142 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Tumour marker increased have been filed in association with ANASTROZOLE (Anastrozole). This represents 1.3% of all adverse event reports for ANASTROZOLE.
142
Reports of Tumour marker increased with ANASTROZOLE
1.3%
of all ANASTROZOLE reports
4
Deaths
12
Hospitalizations
How Dangerous Is Tumour marker increased From ANASTROZOLE?
Of the 142 reports, 4 (2.8%) resulted in death, 12 (8.5%) required hospitalization, and 5 (3.5%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANASTROZOLE. However, 142 reports have been filed with the FAERS database.
What Other Side Effects Does ANASTROZOLE Cause?
Arthralgia (1,409)
Fatigue (1,215)
Nausea (1,049)
Malignant neoplasm progression (1,006)
Diarrhoea (851)
Metastases to bone (758)
Headache (725)
Dyspnoea (678)
Asthenia (649)
Dizziness (596)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which ANASTROZOLE Alternatives Have Lower Tumour marker increased Risk?
ANASTROZOLE vs ANDEXANET ALFA
ANASTROZOLE vs ANDROGEL
ANASTROZOLE vs ANETHOLTRITHION
ANASTROZOLE vs ANGIOTENSIN II
ANASTROZOLE vs ANHYDROUS CITRIC ACID\ASPIRIN\SODIUM BICARBONATE